Correlation Between Pieris Pharmaceuticals and Ocuphire Pharma
Can any of the company-specific risk be diversified away by investing in both Pieris Pharmaceuticals and Ocuphire Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pieris Pharmaceuticals and Ocuphire Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pieris Pharmaceuticals and Ocuphire Pharma, you can compare the effects of market volatilities on Pieris Pharmaceuticals and Ocuphire Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pieris Pharmaceuticals with a short position of Ocuphire Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pieris Pharmaceuticals and Ocuphire Pharma.
Diversification Opportunities for Pieris Pharmaceuticals and Ocuphire Pharma
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pieris and Ocuphire is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Pieris Pharmaceuticals and Ocuphire Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocuphire Pharma and Pieris Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pieris Pharmaceuticals are associated (or correlated) with Ocuphire Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocuphire Pharma has no effect on the direction of Pieris Pharmaceuticals i.e., Pieris Pharmaceuticals and Ocuphire Pharma go up and down completely randomly.
Pair Corralation between Pieris Pharmaceuticals and Ocuphire Pharma
Given the investment horizon of 90 days Pieris Pharmaceuticals is expected to generate 1.57 times more return on investment than Ocuphire Pharma. However, Pieris Pharmaceuticals is 1.57 times more volatile than Ocuphire Pharma. It trades about 0.0 of its potential returns per unit of risk. Ocuphire Pharma is currently generating about -0.02 per unit of risk. If you would invest 7,625 in Pieris Pharmaceuticals on August 29, 2024 and sell it today you would lose (5,918) from holding Pieris Pharmaceuticals or give up 77.61% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 95.56% |
| Values | Daily Returns |
Pieris Pharmaceuticals vs. Ocuphire Pharma
Performance |
| Timeline |
| Pieris Pharmaceuticals |
| Ocuphire Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pieris Pharmaceuticals and Ocuphire Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pieris Pharmaceuticals and Ocuphire Pharma
The main advantage of trading using opposite Pieris Pharmaceuticals and Ocuphire Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pieris Pharmaceuticals position performs unexpectedly, Ocuphire Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocuphire Pharma will offset losses from the drop in Ocuphire Pharma's long position.| Pieris Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Pieris Pharmaceuticals vs. Mereo BioPharma Group | Pieris Pharmaceuticals vs. PDS Biotechnology Corp | Pieris Pharmaceuticals vs. Leap Therapeutics |
| Ocuphire Pharma vs. Reviva Pharmaceuticals Holdings | Ocuphire Pharma vs. Protalix Biotherapeutics | Ocuphire Pharma vs. Eyepoint Pharmaceuticals | Ocuphire Pharma vs. Sellas Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |